Target Name: MKX
NCBI ID: G283078
Review Report on MKX Target / Biomarker Content of Review Report on MKX Target / Biomarker
MKX
Other Name(s): MKX_HUMAN | MKX variant 1 | iroquois homeobox protein-like 1 | mohawk homeobox | C10orf48 | Iroquois family related homeodomain protein | OTTHUMP00000019374 | IRXL1 | IFRX | MGC39616 | Homeobox protein Mohawk | Iroquois homeobox protein-like 1 | Mohawk homeobox, transcript variant 1

MKX: A Protein Involved in Cell Growth, Proliferation and Death

MKX (MKX_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, kidneys, and liver. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of MKX is its role in the regulation of cell proliferation. MKX is a transcription factor, which means it is responsible for turning on the genes that are responsible for cell growth and division. When a cell needs to start dividing, MKX helps to ensure that the necessary changes are made to the DNA so that the cell can properly multiply.

Another important function of MKX is its role in the regulation of cell death. When a cell is no longer needed or is damaged, MKX helps to ensure that it is properly programmed to die. This is important because if cells are allowed to continue dividing and growing indefinitely, they can eventually become cancerous or cause damage to other parts of the body.

MKX is also involved in the regulation of inflammation. When the body is under attack by an infection, MKX helps to ensure that the immune system is able to respond properly. This is important because if the immune system is not able to effectively fight off an infection, it can lead to a range of serious health problems.

In addition to its role in cell regulation, MKX is also a potential drug target. Researchers have identified a number of potential drugs that can inhibit MKX's activity, which could be useful for treating a variety of diseases. These drugs could be used to treat everything from cancer and neurodegenerative diseases to autoimmune disorders and other conditions.

One of the challenges with developing drugs that target MKX is that it is a very versatile protein, with many different functions in the body. This means that it is difficult to predict exactly how a drug will interact with MKX and what it will do. However , researchers are making progress in understanding how MKX works and are developing new drugs that can inhibit its activity.

In addition to its potential as a drug target, MKX is also a valuable biomarker for a number of diseases. Because it is expressed in a variety of tissues throughout the body, researchers have been able to use it as a diagnostic marker for a range of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it an important tool for researchers to study the underlying causes of these diseases and develop new treatments.

Overall, MKX is a protein that is involved in a variety of important functions in the body, including cell regulation and inflammation. As a potential drug target and biomarker, it is an important area of 鈥嬧?媟esearch for researchers to explore and develop new treatments for a range of serious health conditions.

Protein Name: Mohawk Homeobox

Functions: May act as a morphogenetic regulator of cell adhesion

The "MKX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MKX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MLANA | MLC1 | MLEC | MLF1 | MLF1-DT | MLF2 | MLH1 | MLH3 | MLIP | MLIP-AS1 | MLKL | MLLT1 | MLLT10 | MLLT10P1 | MLLT11 | MLLT3 | MLLT6 | MLN | MLNR | MLPH | MLST8 | MLX | MLXIP | MLXIPL | MLYCD | MMAA | MMAB | MMACHC | MMADHC | MMADHC-DT | MMD | MMD2 | MME | MMEL1 | MMGT1 | MMP | MMP1 | MMP10 | MMP11 | MMP12 | MMP13 | MMP14 | MMP15 | MMP16 | MMP17 | MMP19 | MMP2 | MMP2-AS1 | MMP20 | MMP20-AS1 | MMP21 | MMP23A | MMP23B | MMP24 | MMP24-AS1-EDEM2 | MMP24OS | MMP25 | MMP25-AS1 | MMP26 | MMP27 | MMP28 | MMP3 | MMP7 | MMP8 | MMP9 | MMRN1 | MMRN2 | MMS19 | MMS22L | MMS22L-TONSL complex | MMUT | MMXD complex | MN1 | MNAT1 | MND1 | MNDA | MNS1 | MNT | MNX1 | MNX1-AS1 | MOAP1 | MOB1A | MOB1B | MOB2 | MOB3A | MOB3B | MOB3C | MOB4 | MOBP | MOCOS | MOCS1 | MOCS2 | MOCS2-DT | MOCS3 | MOG | MOGAT1 | MOGAT2 | MOGAT3 | MOGS | MOK